Gain-of-Function Research Oversight and NIH Funding Decisions

Disputed

Disputes over federal NIH funding for pathogen enhancement research at the Wuhan Institute of Virology under a grant to EcoHealth Alliance (2014–2019), implementation of a federal gain-of-function research moratorium (2014–2017), and subsequent regulatory decisions regarding biosafety oversight and funding resumption.

AI-generated from public sources and can contain errors — verify claims independently. Learn more

Scientific research & biosafety policy2014-20209 views

Support Webspiracy

Every entry here is AI-generated research, and that costs real API calls to produce. If you've found this useful, a coffee helps keep more entries coming.

Buy me a coffee

Gain-of-Function Research Oversight and NIH Funding Decisions

Program

A contested federal funding and regulatory framework governing pathogen enhancement research oversight, including the 2014–2017 White House moratorium and subsequent decisions on EcoHealth Alliance grants to the Wuhan Institute of Virology.

2014–2017 moratorium on pandemic pathogen research
NIH awarded $3.7M to EcoHealth Alliance 2014–2019
$600K subcontracted to Wuhan Institute of Virology
Moratorium lifted December 2017 under revised oversight

View on Wikipedia

Gain-of-Function Research Oversight and NIH Funding Decisions

Claims and evidence(8)

Sources(10)